Small Molecules
30 January 2015
PREZCOBIX™ (darunavir/cobicistat) Approved in the U.S. for the Treatment of Adults Living With HIV-130 January 2015
PHASE II TRIAL OF ANTICANCER AGENT LENVATINIB IN RENAL CELL CARCINOMA MEETS PRIMARY ENDPOINT29 January 2015
Provectus Biopharmaceuticals Begins Recruitment for Phase 2 Mechanism of Action Clinical Trial Of PH-10 For Psoriasis29 January 2015
Reata Enrolls First Patient in the MOXIe Study, a Phase 2/3 Study Examining RTA 408 in Friedreich’s Ataxia Patients29 January 2015
Novartis announces study in NEJM showing Jakavi® was superior to standard therapy in rare blood cancer polycythemia vera27 January 2015
Can-Fite’s CF602 Demonstrates Efficacy in Treatment of Sexual Dysfunction in Preclinical Studies27 January 2015
Envisia Therapeutics Initiates Phase 2a Clinical Trial for ENV515 in Patients with Glaucoma27 January 2015
New large-scale study to investigate effect of tiotropium + olodaterol Respimat® on exacerbations in COPD27 January 2015
FDA approves first generic esomeprazole26 January 2015
U.S. FDA Approves Rockwell’s Triferic(TM) for Iron Replacement and Maintenance of Hemoglobin in Hemodialysis Patients26 January 2015
Merck Announces CHMP Issues Positive Opinion for Investigational Antibiotic SIVEXTRO® (tedizolid phosphate)23 January 2015
Celgene Receives Positive CHMP Opinion for ABRAXANE® for First-Line Treatment of Patients with Non-Small Cell Lung Cancer23 January 2015
Novartis drug Jakavi® recommended by CHMP for EU approval to treat adults with rare blood cancer polycythemia vera22 January 2015
Heptares Technology Enables Breakthrough in Drug Discovery Collaboration with Astrazeneca22 January 2015
CytRx Announces Overall Survival Results from Its Global Phase 2b Clinical Trial of Aldoxorubicin in Soft Tissue Sarcoma22 January 2015
Alexza Pharmaceuticals Initiates Phase 2a Study of AZ-002 (Staccato® alprazolam) in Epilepsy Patients22 January 2015
European Commission Grants Marketing Authorization for Cerdelga® (eliglustat), Genzyme’s Oral Therapy for Gaucher Disease Type 1News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports